PO
POM.US POMDOCTOR LIMITED American Depositary Shares
- Market cap
- USD 57.9M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is POM.US undervalued?
Graham numberThe Graham number of POMDOCTOR LIMITED American Depositary Shares cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
POMDOCTOR LIMITED American Depositary Shares fundamental analysis
No fundamental analysis for POMDOCTOR LIMITED American Depositary Shares yet.
POMDOCTOR LIMITED American Depositary Shares stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharm…
Full company profilePOMDOCTOR LIMITED American Depositary Shares financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
POMDOCTOR LIMITED American Depositary Shares annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 31.4B | 33.5B | 36.0B | 185M | 144M | 215M | 245M | 305M | 343M | 400M | 239M |
| Gross Profit | 18.7B | 19.5B | 19.3B | 76.5M | 54.9M | 52.5M | 54.9M | 38.7M | 47.7M | 52.3M | 32.7M |
| Operating Income | 3.11B | 4.26B | 3.90B | -64.0M | -246M | -79.7M | -3.59M | -22.2M | -25.8M | -116M | -301M |
| EBITDA | 8.97B | 9.52B | 8.02B | -42.3M | -224M | -58.6M | -3.81M | -23.0M | -24.3M | -118M | -301M |
| Net Income | 1.13B | 2.69B | 398M | -73.1M | -262M | -188M | -126M | -145M | -143M | -213M | -297M |
| EPS | 1.22 | 2.84 | 0.41 | -11 | -40 | -29 | -93 | -69 | -68 | -66 | -38 |
| Balance Sheet | |||||||||||
| Total Assets | 115B | 117B | 120B | 98.9M | 77.3M | 19.3M | 48.6M | 66.3M | 46.2M | 108M | 11.2M |
| Total Liabilities | 89.1B | 86.8B | 88.9B | 151M | 386M | 1.80B | 1.95B | 2.03B | 2.14B | 589M | 85.8M |
| Shareholders' Equity | 25.8B | 29.9B | 30.8B | -52.3M | -309M | -1.85B | -1.97B | -2.12B | -2.26B | -454M | -69.4M |
| Cash & Short-term Investments | 1.55B | 1.87B | 2.15B | 10.6M | 12.9M | 2.17M | 2.49M | 6.72M | 7.65M | 9.58M | 1.86M |
| Total Debt | 34.0B | 34.3B | 35.4B | 77.5M | 114M | 341M | 361M | 413M | 441M | 455M | 66.4M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 8.45B | 7.48B | 8.64B | -59.4M | -35.6M | -15.7M | -22.0M | -45.8M | -16.1M | -148M | 13.0M |
| Capital Expenditure | 8.55B | 7.58B | 7.59B | 200K | 21.17 | 0.00 | 0.00 | 112K | 37.8K | 1.01M | 372K |
| Free Cash Flow | -108M | -104M | 1.05B | -59.6M | -35.6M | -15.7M | -22.0M | -45.9M | -16.2M | -149M | 12.7M |
| Ratios | |||||||||||
| ROE | 4.4% | 9.0% | 1.3% | - | - | - | - | - | - | - | - |
| ROA | 1.0% | 2.3% | 0.3% | -73.9% | -339.2% | -975.6% | -258.2% | -219.3% | -310.1% | -197.6% | -2,646.7% |
| Net Profit Margin | 3.6% | 8.0% | 1.1% | -39.6% | -181.6% | -87.5% | -51.2% | -47.7% | -41.9% | -53.2% | -124.2% |
| Debt to Equity | 1.32x | 1.15x | 1.15x | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
POMDOCTOR LIMITED American Depositary Shares dividends
POMDOCTOR LIMITED American Depositary Shares has not paid dividends in the last 9 fiscal years.
Last stock split: 1:18 on Jun 22, 2026.
Who owns POMDOCTOR LIMITED American Depositary Shares
- Insiders 0.00%
- Institutions 0.01%
- Public & others 99.99%
- Shares outstanding 35.8M
- Free float 1.12M
Top institutions holding POM.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Citadel Advisors Llc | 21.3K | 2.75% | +5.02% | Jun 2026 |
| UBS Group AG | 3.46K | 0.45% | +274.38% | Jun 2026 |
| Caitong International Asset Management Co., Limited. | 893.00 | 0.12% | -49.12% | Jun 2026 |
| SRS Capital Advisors Inc | 722.00 | 0.09% | 0.00% | Jun 2026 |
| Steward Partners Investment Advisory, LLC | 111.00 | 0.01% | 0.00% | Jun 2026 |
| Rhumbline Advisers | 41.00 | 0.01% | 0.00% | Sep 2026 |
| Ground Swell Capital, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Susquehanna International Group, LLP | 0.00 | 0.00% | -100.00% | Jun 2026 |
| Virtu Financial LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| XTX Topco Ltd | 0.00 | 0.00% | -100.00% | Jun 2026 |
| TWO SIGMA SECURITIES, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
POMDOCTOR LIMITED American Depositary Shares company profile
- Company name
- POMDOCTOR LIMITED American Depositary Shares
- Ticker
- POM.US
- ISIN
- KYG7166T1123
- Exchange
- USA Stocks
- Listed since
- Oct 8, 2025
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 165
- Fiscal year end
- December
- Address
- Yongxu Industrial Park, Guangzhou, China, 510000
- Phone
- 86 20 6231 2277
- Website
- 7lk.com
About POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
POMDOCTOR LIMITED American Depositary Shares management
3- Mr. Zhenyang ShiCo-Founder, CEO & Chairman · born 1978
- Ms. Li XuCo-Founder & CFO · born 1975
- Mr. Guoji LuoVP & Director · born 1985